Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
CD22
Description:
A sialic acid-binding receptor expressed mainly on B cells that regulates B-cell signaling and serves as a target in leukemia immunotherapy.
Related topics:
Acute Lymphoblastic Leukemia research (14%),
CAR-T cell therapy research (12%),
T-cell and B-cell Immunology (10%),
Chronic Lymphocytic Leukemia Research (8%),
Lymphoma Diagnosis and Treatment (8%)
OpenAlex ID:
keywords/cd22
CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy
2017
·
Terry J Fry
, Nirali N Shah
, et al.
·
Nature Medicine
·
1,391
The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL.
1994
·
E Matutes
, K Owusu-Ankomah
, et al.
·
PubMed
·
779
CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial
2021
·
Jay Y. Spiegel
, Shabnum Patel
, et al.
·
Nature Medicine
·
662
PDF
Anti-CD22–chimeric antigen receptors targeting B-cell precursor acute lymphoblastic leukemia
2012
·
Waleed Haso
, Daniel W. Lee
, et al.
·
Blood
·
588
Sialic acids as ligands in recognition phenomena
1997
·
Ajit Varki
·
The FASEB Journal
·
540
A Role in B Cell Activation for CD22 and the Protein Tyrosine Phosphatase SHP
1995
·
Gina M. Doody
, Louis B. Justement
, et al.
·
Science
·
539
Siglecs—the major subfamily of I-type lectins
2005
·
Ajit Varki
, Takashi Angata
·
Glycobiology
·
532
Hyperresponsive B Cells in CD22-Deficient Mice
1996
·
Theresa L. O'Keefe
, Gareth T. Williams
, et al.
·
Science
·
532
Chimeric antigen receptor T-cell therapies for lymphoma
2017
·
Jennifer N. Brudno
, James N. Kochenderfer
·
Nature Reviews Clinical Oncology
·
529
Estrogen alters thresholds for B cell apoptosis and activation
2002
·
Christine M. Grimaldi
, James Cleary
, et al.
·
Journal of Clinical Investigation
·
508
CD22 blockade restores homeostatic microglial phagocytosis in ageing brains
2019
·
John V. Pluvinage
, Michael S. Haney
, et al.
·
Nature
·
485
CD4/CD8 T-Cell Selection Affects Chimeric Antigen Receptor (CAR) T-Cell Potency and Toxicity: Updated Results From a Phase I Anti-CD22 CAR T-Cell Trial
2020
·
Nirali N. Shah
, Steven L. Highfill
, et al.
·
Journal of Clinical Oncology
·
449
CD22 is a negative regulator of B-cell receptor signalling
1997
·
Lars Nitschke
, Rita Carsetti
, et al.
·
Current Biology
·
444
PDF
Flow cytometric analysis of human bone marrow. II. Normal B lymphocyte development
1987
·
MR Loken
, VO Shah
, et al.
·
Blood
·
441
PDF
Polygenic Autoimmune Traits: Lyn, CD22, and SHP-1 Are Limiting Elements of a Biochemical Pathway Regulating BCR Signaling and Selection
1998
·
Richard J Cornall
, Jason G Cyster
, et al.
·
Immunity
·
432
PDF
CD22 Is Both a Positive and Negative Regulator of B Lymphocyte Antigen Receptor Signal Transduction: Altered Signaling in CD22-Deficient Mice
1996
·
Shinichi Sato
, Ann S. Miller
, et al.
·
Immunity
·
431
PDF
Improvement of the Chronic Lymphocytic Leukemia Scoring System With the Monoclonal Antibody SN8(CD79b)
1997
·
Elisabeth J. Moreau
, Estella Matutes
, et al.
·
American Journal of Clinical Pathology
·
419
Inotuzumab ozogamicin, an anti-CD22–calecheamicin conjugate, for refractory and relapsed acute lymphocytic leukaemia: a phase 2 study
2012
·
Hagop Kantarjian
, Deborah Thomas
, et al.
·
The Lancet Oncology
·
417
Sialoadhesin, myelin-associated glycoprotein and CD22 define a new family of sialic acid-dependent adhesion molecules of the immunoglobulin superfamily
1994
·
Sørge Kelm
, Andrea Pelz
, et al.
·
Current Biology
·
408
Siglecs, sialic acids and innate immunity
2001
·
Paul R. Crocker
, Ajit Varki
·
Trends in Immunology
·
395
CD22 regulates thymus-independent responses and the lifespan of B cells
1996
·
Kevin L. Otipoby
, Kristin B. Andersson
, et al.
·
Nature
·
389
Thermal ablation of tumor cells with antibody-functionalized single-walled carbon nanotubes
2008
·
Pavitra Chakravarty
, Radu Marches
, et al.
·
Proceedings of the National Academy of Sciences
·
378
Antibody-targeted chemotherapy with CMC-544: a CD22-targeted immunoconjugate of calicheamicin for the treatment of B-lymphoid malignancies
2003
·
John F. DiJoseph
, Douglas C. Armellino
, et al.
·
Blood
·
366
PDF
Bispecific CAR-T cells targeting both CD19 and CD22 for therapy of adults with relapsed or refractory B cell acute lymphoblastic leukemia
2020
·
Hanren Dai
, Zhiqiang Wu
, et al.
·
Journal of Hematology & Oncology
·
351
PDF
The B lymphocyte adhesion molecule CD22 interacts with leukocyte common antigen CD45RO on T cells and α2–6 sialyltransferase, CD75, on B cells
1991
·
Ivan Stamenkovic
, Dennis Sgroi
, et al.
·
Cell
·
341
Show more works
View as search
Works count:
3,318
Citation count:
86,090
Year
Topic
Type